Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (542)	2/24/1998 2:13:00 PM
From: Chip Anderson	Read Replies (2) \| Respond to of 9523

These guys can't even calculate percentages correctly! As of yesterday's close, PFE was up 18.09% for the year, NOT 20%! Jan 2nd close was 75.68, Monday's close was 89.37 - you do the math. Why should anyone listen to people who can't work a calculator? These downgrades suck... Chip coolhistory.com ======== NEW YORK, Feb 24 (Reuters) - Gruntal & Co said Tuesday it lowered its rating on Pfizer Inc to buy from strong buy based on current valuation. -- Pfizer was up 20 percent year-to-date, while the drug index was up 13 percent and the Dow Jones Industrial Average was up 10 percent. -- Pfizer's long-term outlook is among the best in the drug group. -- The stock should move higher on above-average profits bolstered by an unprecedented wave of new product introductions. -- A new one-year target price of $104 was set, up from $86. -- Pfizer was off 2-3/16 at 87-3/16 in midday trading.